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Cells of the weakly CD14 positive human B cell line
RPMI 8226, clone 1, will mobilize NF-B (p50/p65 and
p50/p50) proteins and produce TNF mRNA when stim-
ulated with lipopolysaccharide (LPS). When such cells
are precultured with a low amount of LPS (50 – 250 ng/
ml) for 3 – 4 days followed by a secondary stimulation
with a high dose of LPS (1 g/ml) then the cytokine
expression is strongly reduced, i. e. the cells have be-
come tolerant. 
Western blot analysis of proteins of the NF-B/rel
family demonstrates cytoplasmic p50 and p65 for
naive B cells plus a low level of p52. While with toler-
ance induction the pattern of p50 and p65 proteins re-
mains essentially unchanged, the LPS tolerant 8226
cells show a dramatic increase of both p52 protein and
its p100 precursor in the cytosol. This p52 is found
strongly upregulated in Western blots of extracts from
purified nuclei of tolerant cells. Also, gelshift analysis
with the -605 B motif of the human TNF 5-region
shows an additional high mobility complex in LPS tol-
erant cells – a complex that is supershifted with an
anti-p52 antibody.
Functional analysis with the -1064 TNF 5-region in
front of the luciferase reporter gene demonstrates
that transactivation of the TNF promoter is strongly
reduced in tolerant cells. Also, overexpression of p52
will suppress activity of TNF promoter reporter gene
constructs.
Taken together these data show that tolerance to
LPS in the human RPMI 8226 B cell line involves upreg-
ulation of the p52 (NF-B2) gene, which appears to be
instrumental in the blockade of TNF gene expression.
Key words: Endotoxin / Lipopolysaccharide / 
NF-kappaB / Tolerance.
Introduction
Lipopolysaccharide (LPS) derived from Gram-negative
bacteria is a potent stimulator of monocytes/macro-
phages, leading to rapid production of cytokines like Tu-
mor Necrosis Factor (TNF). LPS acts through binding to
the CD14 receptor (Wright et al., 1990), a process facilitat-
ed by LPS binding protein (Tobias et al., 1986). CD14 is
also expressed at a low level by granulocytes and by B
cells, both of which can be activated through this receptor
(Ziegler-Heitbrock and Ulevitch, 1993). In addition some
other cells that do not express CD14 may be activated by
LPS and this process involves soluble CD14 (Frey et al.,
1992; Pugin et al., 1993). The LPS-sCD14 complex may
act through binding to toll-like receptors TLR2 and TLR4,
which in addition can mediate LPS activation in the ab-
sence of CD14 (Kirschning et al., 1998; Poltorak et al.,
1998; Yang et al., 1998). Hence, LPS can lead to activation
of many cell types, all of which may respond with pro-
duction of proinflammatory cytokines.
When stimulated with LPS repeatedly, monocytes/
macrophages lose their ability to respond (Haas et al.,
1989; Virca et al., 1989; reviewed by Ziegler-Heitbrock,
1995), a process termed desensitization or tolerance. In
monocytes tolerance appears to be mediated by an up-
regulation of the p50 (NF-B1) gene product, which in the
nucleus blocks transactivation of cytokine genes. Recent
evidence indicates that this mechanism of transcriptional
blockade may have more general importance in that it also
occurs in murine macrophages and even in murine T cells
(Sundstedt et al., 1996; Ziegler-Heitbrock et al., 1997).
We now show that a similar but not identical mechanism
appears to operate in a human B cell line. We report that
LPS can induce tolerance in the weakly CD14 positive
RPMI 8226 clone 1 B cell line and we show that no upreg-
ulation of p50 occurs, but that this process involves a dra-
matic increase in the expression of the p52 (NF-B2) gene,
which may be instrumental in blocking gene expression
upon secondary LPS stimulation.
Thus it appears that LPS tolerance in different cell types
operates via a similar mechanism, i. e. through upregula-
tion of a non-transactivating transcription factor. The dif-
ferent cell types do, however, exploit different molecules
to achieve this aim, in that p50 is used by monocytes
while, as shown here, B cells may employ p52 of NF-B.
Results
RPMI 8226 B cells do not express detectable TNF mRNA
without stimulation, but LPS at 1g/ml will induce expres-
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sion of this gene as evidenced by RT-PCR (Figure 1, lanes
1 and 2). When the cells are precultured with a low dose of
LPS (50 ng/ml) for 3 days followed by stimulation with the
high dose of 1g/ml then no TNF mRNA can be induced
(Figure 1, lane 4). These data indicate that the RPMI 8226
cells have become tolerant to LPS stimulation. In classical
systems of tolerance the receptor molecule is down-regu-
lated, and we asked whether the same applies to the B cell
line. The relevant receptor for LPS is the CD14 molecule,
and this molecule was shown to mediate LPS-induced cy-
tokine production in these cells (Ziegler-Heitbrock et al.,
1994a). Flow cytometry analysis did not, however, reveal
any decrease of CD14 expression with tolerance induc-
tion by LPS (data not shown).
We therefore turned to the analysis of molecules in-
volved in signal transduction. One prominent transcription
factor involved in LPS signalling is NF-B. 
Gel shift analysis with the -605 B motif from the human
TNF promoter revealed a low level of constitutive binding,
but with LPS stimulation the nuclear extracts contained
abundant DNA binding proteins with a strong low mobility
(upper) band and a high mobility (lower) band (Figure 2).
Supershift analysis revealed that the upper complex con-
sists of p50 and p65 while the lower complex contains p50
homodimers (data not shown). 
LPS stimulation of tolerant cells revealed an entirely dif-
ferent picture: here some p50/p65 (upper complex) was
still mobilized into the nucleus (Figure 2, lane 4) but an ad-
ditional diffuse band appeared (see arrow in Figure 2) with
somewhat lower mobility as compared to the p50 homo-
dimer.
In supershift analysis of tolerant cells the nuclear ex-
tracts of control treated cells again showed this reduced
mobilization of p50/p65 and a predominance of the new
complex (Figure 3, lane 1). Treatment with anti-p50 anti-
serum removed only the high mobility complex and the
faint low mobility complex (see top and bottom arrow in
Figure 3), such that the new complex became clearly visi-
ble. This complex is supershifted exclusively with anti-p52
antiserum, leaving all the other complexes unaffected.
These data indicate that in tolerant B cells p52 is upreg-
ulated and mobilized into the nucleus where it binds to 
NF-B motifs.
This contention is supported by Western blot analysis.
Cytosolic extracts of naive RPMI 8226 cells contained a
weak p52 band that is diminished upon LPS stimulation
(Figure 4, lanes 1 and 2). In these naive cells no p100 pre-
cursor protein is detected. When the cells are precultured
with LPS however, a strong band for this precursor protein
appears in the cytoplasm and there is also a dramatic in-
crease in the mature p52 protein in LPS-precultured cells
with or without LPS stimulation (Figure 4, lanes 3 and 4).Fig.1 TNF mRNA Expression in RPMI 8226 Cells Induced 
by LPS. 
RPMI 8226 cells were precultured with or without LPS (50 ng/ml)
followed by stimulation with LPS at 1g/ml for 4–6 h. Cell lysates
were spiked with cRNA standard, reverse transcribed and sub-
jected to PCR. Products were separated on agarose gels and
visualized with ethidium bromide (1 of 7 similar experiments). 
Fig.2 LPS-Induced Mobilization of NF-B Proteins in RPMI
8226 Cells.
Cells were precultured with or without LPS (50 ng/ml) followed by
stimulation with or without LPS at 1g/ml. Nuclear extracts were
admixed with the radio-labelled -605 NF-B motif of the human
TNF promoter and separated on a non-denaturing polyacryl-
amide gel. Dryed gels were exposed to X-ray films (1 of 7 experi-
ments).
Fig.3 Supershift Analysis of NF-B Proteins from Nuclear
Extracts of Naive and Tolerant RPMI 8226 Cells.
Nuclear extracts from cells with or without preculture with LPS at
50 ng/ml followed by stimulation with LPS at 1g/ml were ad-
mixed with polyclonal antibodies against different NF-B/rel pro-
teins, followed by addition of radio-labelled -605 NF-B motif of
the human TNF promoter. After separation on a non-denaturing
polyacrylamide gel the dried gel was exposed to an X-ray film (1 of
3 experiments).
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 19.11.13 16:56
Analysis of nuclear extracts (Figure 4, lanes 5 – 8) shows
no p100 band anywhere (which demonstrates that there 
is no cytoplasmic contamination of the sucrose-gradient
purified nuclei). p52 protein is found in very low abun-
dance in nuclei of naive cells and this increases somewhat
with LPS stimulation (Figure 4, lanes 5 and 6). Upon LPS
preculture nuclear p52 increases dramatically both with
and without additional LPS stimulation (Figure 4, lanes 7
and 8). These data show that the unique feature in LPS tol-
erant RPMI 8226 B cells is the upregulation of p52 protein,
which is mobilized into the nucleus.
Next we analyzed the functional consequences of the
increased expression of p52. For this we studied the ac-
tivity of the 5 region (-1064 bp) of the TNF gene in a lu-
ciferase reporter construct. DEAE-dextran transfected
naive RPMI 8226 cells gave an average 12-fold increase in
luciferase enzyme activity when stimulated with LPS. In
tolerant cells transactivation was only 2.5-fold (Figure 5).
Similar data were obtained with reporter gene constructs
containing a trimer of the -605 NF-B site of the TNF pro-
moter (data not shown). This indicates that tolerance is
operative at the transcriptional level.
Finally we asked whether overexpression of p52 direct-
ed by an expression plasmid is able to down-regulate
transactivation from the human TNF promoter. HEK293
cells were cotransfected with a TNF promoter luciferase
reporter plasmid plus different expression plasmids. As
shown in Figure 6, cotransfection with p65 will strongly en-
hance TNF promoter activity by an average factor of 22
(compare columns 1 and 2, Figure 6). This enhanced re-
porter gene activity is counteracted by overexpression of
p52, which reduces activity to 20% of the p65 value (Fig-
ure 6, column 3), while the empty expression plasmid even
leads to a slight increase in luciferase activity.
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Fig.4 Western Blot Analysis of Cytosolic and Nuclear NF-B2
Gene Products.
Cells were precultured for 3 days with or without LPS (100 ng/ml)
followed by stimulation with or without LPS at 1g/ml for 1h. Cy-
tosolic extracts were then prepared directly by ultrasound disrup-
tion For nuclear extracts viable cells were first purified by ficoll-
hypaque density gradient separation, nuclei were obtained by
douncing and these were separated over a 57% (w/v) sucrose
gradient, followed by extract preparation under low salt condi-
tons. Thirty g of cytosolic protein or 6 g of nuclear protein per
lane were separated on a Tris-glycine gel and blots were reacted
with an antibody against human p52 followed by goat anti-rabbit
peroxidase and ECL reagent.
Fig.5 TNF Promoter Reporter Gene Analysis in Naive and
Tolerant RPMI 8226 Cells.
Cells were transfected by DEAE-dextran with the pTNF-1064
luci- construct and were precultured with or without LPS (250
ng/ml) for 4 days. After stimulation with LPS (1g/ml for 4 h), cell
lysates were obtained by 3 freeze-thaw cycles and luciferase en-
zyme activity was determined in a luminometer. Relative light
units (RLUs) for LPS-stimulated naive cells were set at 100%.
RLUs for the 100% value were on the order of 25  104 per 100 g
of protein. Average + SD of 5 experiments.
Fig.6 Supression of TNF Promoter Activity by p52 (NF-B2).
The human TNF promoter luciferase reporter gene construct was
cotransfected with expression plasmids encoding for p65 or p52
or with an empty expression plasmid (control) using the Ca-phos-
phate procedure. After overnight culture cell lysates were ob-
tained by 3 freeze-thaw cycles and luciferase enzyme activity was
determined in a luminometer. Relative light units for cells trans-
fected p65 were set at 100%. RLUs for the 100% value were on
the order of 8  106 per g protein. Average + SD of 3 experi-
ments.
Discussion
The phenomenon of tolerance to LPS was noted early on
with respect to the febrile response of the rabbit (Beeson,
1947). It was suggested to be controlled at the cellular
level (Greisman et al., 1966) and in fact later on LPS toler-
ance was adoptively transferred by mouse macrophages
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(Freudenberg and Galanos, 1988). LPS tolerance was
then adapted to in vitro treatment of monocyte/macro-
phage cell lines like Mono Mac 6 or RAW 264.7 (Haas et al.,
1989; Virca et al., 1989) and here it was shown that the TNF
gene was down-regulated at the mRNA level. While down-
regulation of TNF is the salient feature of LPS tolerance
other products of monocytes may even be upregulated
(Zhang and Marrison, 1993; Knopf et al., 1994; West et al.,
1997) and this includes anti-inflammatory molecules like
IL-10 and IL-1 receptor antagonist (Frankenberger et al.,
1995; Randow et al., 1995). 
Since the cell surface receptor for LPS, the CD14 mole-
cule, appeared not to be down-regulated in LPS tolerance
(Mathison et al., 1993; Ziegler-Heitbrock et al., 1994b) it
was speculated that elements of signal transduction
might be altered. We have hypothesized that p50/p50 ho-
modimers may fulfill such a function in LPS tolerant mono-
cytes (Ziegler-Heitbrock et al., 1994b, 1995). In the present
report we asked whether a similar mechanism may oper-
ate in human B cells.
Human B cells may express a low level of CD14 on the
cell surface (Labeta et al., 1991; Medeiros et al., 1991;
Morabito et al., 1987; Ziegler-Heitbrock et al., 1988). We
have isolated RPMI 8226 clones from the B cell line that
exibit stable expression of CD14. LPS stimulation of such
cells will lead to expression of cytokines IL-6, IL-10
(Ziegler-Heitbrock et al., 1994a) and TNF (this study). TNF
is, in fact, a cytokine that is readily expressed by B cells
(Goldfeld and Maniatis, 1989; Sung et al., 1988).When the
RPMI 8226 cells are precultured with LPS followed by a
secondary LPS stimulation, then TNF mRNA expression is
strongly reduced (Figure 1), demonstrating that tolerance
to LPS can be induced and can be analyzed by looking at
TNF gene expression.
Based on earlier studies in monocytes we analyzed the
NF-B transcription factor complex in the RPMI 8226 B
cell line.
The p52 protein appears to be of crucial importance in
LPS tolerance in this cell line since Western blot analysis
demonstrates a pronounced upregulation of p52 and its
p100 precursor. The upregulated p52 was also readily
detected in gelshift analysis and could be identified by
supershift with anti-p52 (Figure 3).
In monocytes this increased transcription factor com-
plex represents p50 homodimers, which appear to be re-
sponsible for tolerance in that they occupy NF-B sites
without transactivation such that expression of genes like
TNF is blocked (Ziegler-Heitbrock et al., 1994b, 1995). In
fact, p50 knock-out mice were shown not to develop LPS
tolerance and overexpression of p50 in cotransfection ex-
periments blocked TNF gene expression (Bohuslav et al.,
1998; Kastenbauer and Ziegler-Heitbrock, 1999). For
RPMI 8226 cells the present study clearly demonstrates
that p50 is not involved but products of the NF-B2 gene,
i. e. p52 and its precursor, p100 are upregulated. Since
p52 lacks a transactivation domain, its binding to DNA
may lead to a blockade of transcription since transactivat-
ing complexes do not get access to the site. 
Several reports have documented that overexpression
of p50 or p52 can lead to reduced gene expression
(Schmitz and Bäuerle, 1991; Franzoso et al., 1992; Plaksin
et al., 1993; Dobrzanski et al., 1995). Here we could
demonstrate that overexpression of such p52 is capable
of suppressing the human TNF promoter activity.
While this is the first study to describe a role for p52 in
LPS tolerance, there have been several studies by others
that support our general concept (Ziegler-Heitbrock et al.,
1994b) of transcriptional blockade by a non-transactivat-
ing NF-B complex. Lægreid et al. noted that preculture of
SW480 adenocarcinoma cells with agonistic TNF recep-
tor antibodies led to a strong increase of p50 homodimers
in gelshift analysis (Lægreid et al., 1995). Also, Sunstedt et
al. (1996) found in TCR transgenic mice that repeated in-
jection of superantigen in vivo resulted in a predominance
of p50/p50 homodimers in the tolerant T cells.
Studies failed to detect an increase of p50/p50 in LPS
tolerance that analyzed responses after very short periods
(4 – 5 h) of tolerance induction (Takasuka et al., 1995;
Kravchenko et al., 1996), which may be too short to allow
for induction of expression of NF-B1 and 2 genes.
Of note, the detection of p50/p50 homodimers in gel-
shift assays does require DNA binding motifs that read
CCC at the 3end. Motifs that contain only CC are unable
to bind p50/p50 with sufficient affinity (Kunsch et al., 1992;
Frankenberger and Ziegler-Heitbrock, 1997) to allow for
their detection in gelshift.
In LPS tolerance there are several possible levels of reg-
ulation that may account for the non-responsiveness. This
includes the level of G-proteins, of kinases or other ele-
ments of signal transduction, the transcriptional level, the
translational regulation via AU-rich 3-elements of the
mRNA, or post-translational effects (Zuckerman et al.,
1989; Coffee et al., 1992; Marchant et al., 1996). While all
of these may contribute to the non-responsiveness to a
varying degree, we do suggest that the blockade of gene
expression via upregulation of a non-transactivating NF-
B complex will explain a large part of the observed effect
and will provide a general mechanism that counteracts the
action of classical NF-B on a variety of genes.
Since tolerance to LPS may be induced by different
types of stimuli (reviewed by Cavaillon, 1995) we may
speculate that these stimuli also lead to an increased ex-
pression of the genes for either p50 (NF-B1) or, as sug-
gested by the present report, also for p52 (NF-B2). Fur-
thermore, as discussed above, the concept of transcrip-
tional blockade via NF-B1 or 2 gene products may not
only extend to other inducers of LPS tolerance but also to
tolerance to stimulation via TNF receptors or T cell recep-
tors.
Material and Methods
Cell Culture
In a previous study the original RPMI 8226 B cell line (Matsuoka et
al., 1967) was found to inconsistently express cell surface CD14.
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We derived a subclone, termed clone 1, which shows stable ex-
pression of CD14 (Ziegler-Heitbrock et al., 1994a) and this clone
was used throughout this study. The cells were cultured in RPMI
1640 fortified with non-essential amino acids, L-glutamine, strep-
tomycin and penicillin.
This medium was ultrafiltered through a Gambro 2000 column
(Gambro, Hechingen, Germany) in order to remove contaminant
LPS, followed by addition of 10% fetal calf serum. The cells were
cultured in 75 cm2 flasks (Costar, Cambrige, MA, USA) or 6-well
plates (Costar), with or without LPS from S. minnesota (Sigma,
Deisenhofen, Germany), at 50 – 250 ng/ml for 3 – 4 days. The
slightly adherent cells were then recovered with a cell scraper,
washed twice, adjusted to 2 –10 106 cells/ml and were stimu-
lated with LPS at 1g / ml for 1– 6 hours.
Flow Cytometry
For analysis of CD14 cell surface expression, cells with and with-
out LPS preculture were reacted on ice with either FITC-con-
jugated My-4 or with the respective isotype control (Coulter,
Krefeld, Germany) followed by analysis of 10000 cells per sample
in an EPICS V flow cytometer (Coulter).
Western Blotting
Cytoplasmic or nuclear proteins (10 – 20 g/lane) were separated
on 4 –12% Tris/glycine gels (Novex through Anamed, Offenbach,
Germany) and were transferred to Hybond ECL (enhanced
chemoluminescence) nitrocellulose membranes (Amersham,
Braunschweig, Germany) by electroblotting. Membranes were
reacted with 1:5000 dilutions of antibodies against p50, p52 and
p65 that were kindly provided by Nancy Rice (Frederick, MD,
USA). After reaction with F(ab)2 goat anti-rabbit Ig peroxidase
conjugate (1:10000, Sigma), blots were incubated with ECL
reagent (Amersham) and exposed to Hyperfilm ECL (Amersham).
TNF-PCR
The determination of TNF mRNA expression was performed es-
sentially as described (Frankenberger et al., 1995). In brief, cell
lysates taken after 4 h of stimulation were admixed with cRNA
standard. The total RNA was isolated and reverse-transcribed us-
ing oligo (dT) primers. The cDNA was then amplified with specific
primers and after 45 cycles the product was separated on a 1.4%
agarose gel in the presence of ethidium bromide.
Gel Shift Analysis
Nuclear extracts were isolated according to Dignam et al. (1983)
and were admixed with a [32P]-labeled double-stranded oligonu-
cleotide representing the -605 NF-B site of the human TNF pro-
moter (Ziegler-Heitbrock et al., 1993). After 15 min of incubation at
21˚C samples were electrophoresed on nondenaturing polyacryl-
amide gels in 0.25  TBE buffer (22.5 mM Tris-borate, 0.5 mM
EDTA, pH 8.5). 
For supershift analysis 2 l of the respective antibody or pre-
immune serum were added subsequently to the [32P]-labeled
oligonucleotide, and the samples were incubated another 30 min
on ice. Anti-p50 (serum 2), was kindly provided by A. Israël, Insti-
tut Pasteur, Paris, France, (Kieran et al., 1990). Anti-p52 was pre-
pared against amino acids 2 –18 of the human protein (Nancy
Rice, personal communication), kindly provided by Nancy Rice,
Frederick, MD, USA. The other antibodies (anti-p65 = sc-372X , 
c-rel = sc-70X and relB = sc-226X) were purchased from Santa
Cruz Biotechnology, Santa Cruz, CA, USA. 
Reporter Gene Analysis
The pTNF-1064 luci- reporter plasmid containing the human
TNF 5-region was obtained by exchanging the mouse -globin
promoter of the pTATA luci- reporter plasmid against the 
HindIII/BglII fragment from the TNF 5-region pxP2 luciferase
construct (Ziegler-Heitbrock et al., 1994b). The pTATA.luci re-
porter plasmid contains 3 to the luciferase gene the rabbit 
globin intron (Kastenbauer et al., 1996).
RPMI 8226 cells were transfected with the constructs (2 – 5 g
of DNA/ 107 cells) according to Shakhov et al. (1990) using DEAE-
dextran (62.5 g/ml). Cells were then cultured for 4 days with or
without LPS (250 ng/ml), followed by LPS stimulation (1g/ml) for
4 h. Luciferase activity in cell lysates was determined using a
Model LB9501 luminometer (Berthold, Wildbad, Germany) and
the Luciferase Assay System (E1500) from Promega (Madison,
Wisconsin, USA).
For cotransfection analysis HEK293 cells were seeded at 5 
105 cells per well in 6-well plates (Costar) and cultured overnight.
Duplicates of 2 wells each were then transfected by the Ca-phos-
phate method with luciferase reporter plasmid alone (2 g), with
luciferase reporter plasmid plus 1g of RCCMVp65 (Schmitz
and Bäuerle, 1991, kindly provided by P.A. Bäuerle, Freiburg, Ger-
many) or with luciferase reporter plasmid plus 1g of RCCMVp65
plus either 1g of RCCMVp52 expression plasmid (constructed
by Alain Israël by cloning the HindIII-PstI fragment that codes for
amino acids 1– 441 of p100 into the RcCMV plasmid, kindly pro-
vided by A. Israël, Institut Pasteur Paris, France) or 1g of RcCMV
empty expression plasmid. Cellular luciferase activity with
measured after 24 h.
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